Sign in

Maria Angelidis-Smith

Director at LemonadeLemonade
Board

About Maria Angelidis-Smith

Maria Angelidis-Smith (age 46) joined Lemonade’s Board in October 2024 and is classified as a Class I Director with a term expiring at the 2027 Annual Meeting. She is currently Chief Product and Technology Officer at Personio and previously served as a VP of Product and GM at Meta, with earlier roles at Intuit and The Boston Consulting Group. She holds a BBA from Athens University of Economics and Business and an MBA from the University of Michigan Ross School of Business, where she was a Fulbright Scholar .

Past Roles

OrganizationRoleTenureCommittees/Impact
MetaVice President of Product; General Manager (Facebook App monetization; Groups, Events, Profile)Not disclosedLed monetization and scaled billion+ user products
IntuitLeadership roles (product development, growth strategies, marketing)Not disclosedProduct and growth-focused leadership
The Boston Consulting GroupLeadership rolesNot disclosedStrategy and marketing-focused roles

External Roles

OrganizationRoleTenureNotes
PersonioChief Product and Technology OfficerCurrentEurope’s leading HR software for SMBs

Board Governance

  • Independence: The Board determined Angelidis-Smith is independent under NYSE listing standards .
  • Board structure: Combined CEO/Chair (Daniel Schreiber) with a Lead Independent Director (Michael Eisenberg); non-management director executive sessions occur at least twice per year .
  • Attendance: In 2024, the Board met 6 times; each director attended at least 75% of Board and committee meetings on which they served. Audit Committee met 4 times .
  • Committee memberships and chairs:
DirectorAuditCompensationNominating & Corporate Governance
Michael EisenbergChair X
Dr. Samer Haj‑YehiaChair X
Debra SchwartzX Chair
Maria Angelidis‑SmithX X
  • Audit Committee independence and literacy: Members (Haj‑Yehia, Schwartz, Angelidis‑Smith) deemed independent; Haj‑Yehia and Schwartz are “audit committee financial experts” .
  • Compensation Committee: Members (Eisenberg—Chair, Haj‑Yehia, Angelidis‑Smith) all independent; acted by unanimous written consent in 2024; engaged Aon HCS as independent compensation consultant; no consultant conflicts identified .

Fixed Compensation

YearCash Fees (USD)Notes
2024$7,160 Earned in quarter-year since October 2024 appointment

Director cash fee policy (general, applied quarterly):

  • Annual director cash fee: $20,000
  • Audit Committee: Chair $20,000; Member $7,500
  • Compensation Committee: Chair $10,000; Member $5,000
  • Nominating & Governance: Chair $7,500; Member $3,500

Performance Compensation

Award TypeGrant Value (USD)Grant DateVestingChange-of-Control Treatment
Initial RSU (upon commencement)$175,000 (policy) At start of service (Oct 2024) Vests in 3 equal annual installments on 1st–3rd anniversaries of start date Accelerated vesting upon change in control under 2020 Plan
Annual RSU (post-AGM)$150,000 (policy) Following each annual meeting Vests on first anniversary of grant Accelerated vesting upon change in control under 2020 Plan
Actual 2024 Stock Awards$174,995 2024RSUs; service-based vesting (no performance conditions disclosed) Accelerated vesting upon change in control

Note: Director equity awards are time-based RSUs; no specific performance metrics (e.g., TSR, EBITDA) disclosed for director grants .

Other Directorships & Interlocks

CompanyBoard RoleCommittee RolesInterlocks/Notes
None disclosedCompensation Committee Interlocks: None; no officer/employee members; no reciprocal interlocks reported for 2024

Expertise & Qualifications

  • Product and technology leadership across Personio and Meta; experience scaling revenue and user-facing platforms .
  • Strategic and growth expertise from Intuit and BCG roles .
  • Education: BBA (Economics/Operations/Marketing), Athens University of Economics and Business; MBA, Michigan Ross; Fulbright Scholar .

Equity Ownership

HolderShares Beneficially Owned% of Shares OutstandingUnvested RSUs Outstanding at FY 2024 End
Maria Angelidis‑Smith33,554 <1% (on 73,266,170 shares outstanding) 7,362

Policy controls relevant to alignment:

  • Insider Trading Policy prohibits hedging, short sales, pledging, margin purchases, and placing company securities in margin accounts for directors and employees .

Governance Assessment

  • Strengths: Independent director on Audit and Compensation Committees; strong product/technology background—valuable for Lemonade’s digital insurance strategy; Board reports robust risk oversight with Audit Committee coverage of cyber and financial reporting; high-level meeting attendance threshold met .
  • Alignment: Material portion of her 2024 director compensation is equity-based RSUs ($174,995 vs. $7,160 cash), supporting shareholder alignment; beneficial ownership disclosed with additional unvested RSUs .
  • Process quality: Compensation Committee uses an independent consultant (Aon HCS) and found no conflicts; committee acted by unanimous written consent, indicating governance rigor .
  • Potential concerns/RED FLAGS: No director-specific related-party transactions disclosed in provided excerpts; company-level governance note of combined CEO/Chair role is mitigated by Lead Independent Director and regular executive sessions, but remains a structural consideration for some investors . No evidence of pledging or hedging by the director; policy prohibits such practices .

Director Compensation Mix (2024)

ComponentAmount (USD)Mix (%)
Cash Fees$7,160 3.9%
Stock Awards (RSUs, grant-date fair value)$174,995 96.1%
Total$182,155 100%

Board Governance Details

  • Board composition and classes: Class I (Daniel Schreiber, Maria Angelidis‑Smith); Class II (Shai Wininger, Dr. Samer Haj‑Yehia); Class III (Michael Eisenberg—Lead Independent Director, Debra Schwartz). Directors removable only for cause by supermajority; staggered terms may delay change of control .
  • Audit Committee report and auditor fees: EY total fees $3,145,964 (2024) vs. $3,113,473 (2023); categories detailed; Audit Committee oversight affirmed auditor independence .

Related-Party Transactions

  • Policy: Audit Committee must review and approve related person transactions; ratification/cancellation procedures in place; directors cannot participate in approvals where they are a related person .
  • Director-specific transactions: None involving Angelidis‑Smith are disclosed in the provided sections .